Search

everythinglearnresearchcommunity

for

Search:↓

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Ritlecitinib can help about 14,000 people with severe hair loss.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.